OPKO Health, Inc. (BMV:OPK)
Mexico
· Delayed Price · Currency is MXN 20.86
-1.01 (-4.62%)
At close: Feb 10, 2026
OPKO Health Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Revenue | 606.88 | 713.14 | 863.5 | 1,004 | 1,775 | Upgrade
|
| Revenue Growth (YoY) | -14.90% | -17.41% | -14.01% | -43.42% | 23.64% | Upgrade
|
| Cost of Revenue | 524.97 | 599.85 | 634.96 | 789.86 | 1,270 | Upgrade
|
| Gross Profit | 81.91 | 113.3 | 228.53 | 214.33 | 504.67 | Upgrade
|
| Selling, General & Admin | 223 | 303.02 | 300.56 | 372.67 | 468.86 | Upgrade
|
| Amortization of Goodwill & Intangibles | 77.89 | 82.63 | 86.03 | 87.78 | 50.28 | Upgrade
|
| Operating Expenses | 300.89 | 385.65 | 386.59 | 460.46 | 519.14 | Upgrade
|
| Operating Income | -218.99 | -272.36 | -158.06 | -246.12 | -14.46 | Upgrade
|
| Interest Expense | -108.46 | -47.47 | -13.51 | -12.06 | -18.88 | Upgrade
|
| Interest & Investment Income | 14.81 | 8.43 | 3.98 | 1.98 | 0.03 | Upgrade
|
| Earnings From Equity Investments | -0.03 | -0.02 | -0.11 | -0.38 | -0.63 | Upgrade
|
| Currency Exchange Gain (Loss) | -2 | -3.8 | 1.2 | -1.8 | -1.4 | Upgrade
|
| Other Non Operating Income (Expenses) | -28.06 | 164.69 | -18.42 | -149.83 | 3.46 | Upgrade
|
| EBT Excluding Unusual Items | -342.73 | -150.52 | -184.91 | -408.21 | -31.88 | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.24 | 19.85 | -0.56 | -3.57 | -4.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | 101.58 | 121.49 | - | 18.56 | 31.51 | Upgrade
|
| Asset Writedown | - | -1.2 | - | - | - | Upgrade
|
| Other Unusual Items | - | - | 1.04 | 1.31 | -9.41 | Upgrade
|
| Pretax Income | -241.39 | -10.38 | -184.43 | -391.9 | -14.65 | Upgrade
|
| Income Tax Expense | -15.71 | 42.84 | 4.44 | -63.5 | 15.49 | Upgrade
|
| Earnings From Continuing Operations | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 | Upgrade
|
| Net Income | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 | Upgrade
|
| Net Income to Common | -225.68 | -53.22 | -188.86 | -328.41 | -30.14 | Upgrade
|
| Shares Outstanding (Basic) | 751 | 694 | 752 | 719 | 648 | Upgrade
|
| Shares Outstanding (Diluted) | 751 | 694 | 752 | 719 | 648 | Upgrade
|
| Shares Change (YoY) | 8.23% | -7.68% | 4.55% | 10.95% | 1.16% | Upgrade
|
| EPS (Basic) | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 | Upgrade
|
| EPS (Diluted) | -0.30 | -0.08 | -0.25 | -0.46 | -0.05 | Upgrade
|
| Free Cash Flow | -190.82 | -208.5 | -44.47 | -119.77 | 6.18 | Upgrade
|
| Free Cash Flow Per Share | -0.25 | -0.30 | -0.06 | -0.17 | 0.01 | Upgrade
|
| Gross Margin | 13.50% | 15.89% | 26.47% | 21.34% | 28.44% | Upgrade
|
| Operating Margin | -36.08% | -38.19% | -18.30% | -24.51% | -0.81% | Upgrade
|
| Profit Margin | -37.19% | -7.46% | -21.87% | -32.70% | -1.70% | Upgrade
|
| Free Cash Flow Margin | -31.44% | -29.24% | -5.15% | -11.93% | 0.35% | Upgrade
|
| EBITDA | -127.36 | -174.18 | -52.76 | -137.47 | 64.26 | Upgrade
|
| EBITDA Margin | -20.99% | -24.42% | -6.11% | -13.69% | 3.62% | Upgrade
|
| D&A For EBITDA | 91.63 | 98.18 | 105.3 | 108.66 | 78.72 | Upgrade
|
| EBIT | -218.99 | -272.36 | -158.06 | -246.12 | -14.46 | Upgrade
|
| EBIT Margin | -36.08% | -38.19% | -18.30% | -24.51% | -0.81% | Upgrade
|
| Revenue as Reported | 606.88 | 713.14 | 863.5 | 1,004 | 1,775 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.